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Plasticity in energymetabolism allows stem cells tomatch the divergent demands of self-renewal and lineage
specification. Beyond a role in energetic support, new evidence implicates nutrient-responsive metabolites
as mediators of crosstalk between metabolic flux, cellular signaling, and epigenetic regulation of cell fate.
Stem cell metabolism also offers a potential target for controlling tissue homeostasis and regeneration in
aging and disease. In this Perspective, we cover recent progress establishing an emerging relationship
between stem cell metabolism and cell fate control.Metabolism (from the Greek mεtabolh , i.e., transition, transfor-
mation) supports fundamental processes throughout life, as cells
require a continuous yet adaptable energy supply to meet the
demands of their specialized functions. Metabolic flexibility
fuels divergent stem cell fates, which include quiescence tomini-
mize stress damage, proliferation and self-renewal to maintain
progenitor pools, and lineage specification for tissue regenera-
tion. These vital processes are powered through the metabolism
of energy substrates supplied by the environment, such as
glucose, fatty acids, and amino acids. Catabolism, the process
of breaking down (oxidizing) metabolites to produce energy,
and anabolism, the process of constructing macromolecules
from precursors, are tightly balanced. As a result, catabolic
products, including hydrocarbons and energy in the form of
ATP and reducing cofactors, serve as substrates for the anabolic
production of macromolecules that cannot be obtained from the
environment. Beyond providing energetic supply, metabolic
circuits engage master genetic programs in control of cell
behavior (McKnight, 2010), with cellular identity and functional
state reflecting the specific metabolic pathways being used.
This Perspective highlights the plasticity in stem cell metabolism,
which enables prioritization of metabolic pathways to match
anabolic and catabolic demands of evolving identities during
cell fate determination.
Metabolism Fuels Developmental Organogenesis
The one-cell embryo preferentially metabolizes pyruvate over
glucose, extending themetabolic pattern of the oocyte (Figure 1).
Initial oxidative metabolism in the embryo relies on abundant
maternal mitochondria inherited from the oocyte. Early cell divi-
sions in the preimplantation embryo result in discrete mitochon-
drial segregation, leading to reduced mitochondrial DNA copy
number and density, as replication is initiated after implantation.
This yields populations of progenitor cells with a spectrum of
heteroplasmy, or mixture of healthy and mutated mitochondrial
DNA (mtDNA). Mitochondrial patterning allows blastomeres to
purge metabolism-deficient progeny harboring disproportionally
high levels of maternally derived mutant mtDNA, thus selecting
for healthy metabolic profiles and preventing mutational melt-
down in subsequent generations (Fan et al., 2008; Shoubridge
and Wai, 2008). Despite their functional capacity to produce596 Cell Stem Cell 11, November 2, 2012 ª2012 Elsevier Inc.ATP from oxidative metabolism, mitochondria of oocytes and
newly fertilized eggs are structurally undeveloped, consisting
of spherical structures with truncated cristae that predominantly
reside near the nucleus (Van Blerkom, 2009). Glucose uptake
gradually increases in the morula and is accelerated in the blas-
tocyst stage where glucose uptake exceeds that of pyruvate or
lactate and is predominantly metabolized through glycolysis
(Johnson et al., 2003). Priming of the glycolytic system may
occur in anticipation of implantation into the hypoxic uterine
wall, as glucose uptake is further accelerated following implan-
tation, where virtually all glucose is metabolized to lactate.
During later development, mitochondrial replication, maturation
into tubular cristae-dense structures, and cytosolic deployment
enables reinitiation of oxidative metabolism and progressive
decline in glycolysis (Johnson et al., 2003; Van Blerkom, 2009).
The chronology of metabolic regimes is underscored by
embryonic phenotypes that reflect disrupted metabolic pro-
cesses (Johnson et al., 2003). Glycolytic gene mutations precip-
itate early postimplantation lethality, while defects in oxidative
processes, such as pyruvate dehydrogenase mutations or
genetic disruption of the mitochondrial transcription factor
TFAM, result in developmental delay and/or late onset lethality
(Johnson et al., 2003; Larsson et al., 1998). The maturation of
more efficient metabolic infrastructure during development has
also been documented in highly specialized tissues. Cardiomyo-
cytes from day 9.5 embryos (e9.5) contain few fragmented
mitochondria with poorly defined and unorganized cristae,
similar to those in the early embryo, which undergo extensive
maturation into filamentous networks of elongated and branched
mitochondria with abundant and organized cristae by day e13.5
(Hom et al., 2011). Cardiomyocyte development is dependent
on mitochondrial status, as early induction of mitochondrial
maturation accelerates cardiomyocyte differentiation, while
differentiation is impaired when mitochondria are arrested in
the immature state (Folmes et al., 2012b; Hom et al., 2011).
Progenitors in the developing retina are dependent on glycolytic
flux from endogenous stores, such as glycogen, for proliferation
and survival, while forced differentiation switches glycolysis into
oxidative metabolism for ATP generation (Agathocleous et al.,
2012). Metabolic plasticity thus enables flexibility in energetic
substrate choice, which is critical for proper development.
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Figure 1. Metabolic Dynamics during Development
Mitochondria and energy metabolism undergo dramatic remodeling during embryonic development. Early embryos are initially dependent upon oxidative
metabolism due to inheritance ofmaternal mitochondria from the oocyte, which are subsequently segregated among daughter cells, as replication is only initiated
after implantation. There is a concomitant acceleration of anaerobic glycolysis, which peaks following implantation and slowly declines as oxidativemetabolism is
reinitiated due to vascularization. PPP, pentose phosphate pathway.
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Different cell states require specific metabolic programs to
support the unique bioenergetic demands underlying their
specialized functions. Flexibility in metabolic pathway utilization
maintains a balance of anabolic processes to support synthesis
of cellular building blocks, and catabolic processes to ensure
adequate bioenergetic resources. Metabolic requirements are
defined by the energetic demands of stem cell proliferation,
lineage specification, and quiescence. As such, metabolism at
a stemness ground state is unable to fulfill the needs of differen-
tiated progeny. Conversely, metabolic metamorphosis underlies
pluripotent induction during nuclear reprogramming.
Glycolysis Fuels Anabolism for Stem Cell Proliferation
and Self-Renewal
Proliferating cells have a high requirement for not only reducing
cofactors (NADPH) and energy (ATP), but also carbon, nitrogen,
and hydrogen to support biosynthesis of cell building blocks
required for replication (Vander Heiden et al., 2009; Zhang
et al., 2012 in this issue of Cell Stem Cell). Complete consump-
tion of available substrates cannot support their anabolic
requirements. Rather, partial breakdown of glucose through
glycolysis and shunting of intermediates through the pentosephosphate pathway provide a compromise between catabolic
generation of ATP and reducing cofactors, and production
of biosynthetic substrates to meet anabolic requirements
(Figure 2). Indeed, increased expression of glycolytic enzymes
and stimulation of glycolysis is required for cell immortalization
and is sufficient to increase cellular lifespan (Kondoh et al.,
2005). Although glycolysis is inherently less efficient, producing
a fraction of ATP compared to oxidative consumption of
glucose, glycolysis does enable a fast rate of energy genera-
tion. Under abundant supply of glucose, the percentage of
ATP generated from glycolysis can surpass that produced by
oxygen-dependent respiration (Guppy et al., 1993). As such,
mitochondria may redirect away from oxidative ATP generation
to cataplerosis, enabling extraction of partially oxidized
substrates from the tricarboxylic acid (TCA) cycle for biosyn-
thetic purposes. Similar to the early embryo, embryonic stem
cells (ESCs) have a low mtDNA copy number and harbor
a sparse mitochondrial infrastructure with immature cristae
and limited perinuclear localization (Chung et al., 2007). Such
mitochondrial infrastructure is also characteristic of hematopoi-
etic stem cells (HSCs) (Piccoli et al., 2005) and mesenchymal
stem cells (MSCs) (Chen et al., 2008b; Lonergan et al., 2006),Cell Stem Cell 11, November 2, 2012 ª2012 Elsevier Inc. 597
Figure 2. Metabolic Pathways for Stemness Maintenance
Catabolic and anabolic pathways are interconnected to provide stem cells sufficient energy for homeostasis while producing requisite macromolecules for
daughter cell replication. Complete oxidation of pyruvate and glutamine through the tricarboxylic acid cycle (TCA) would not meet the demand for anabolic
precursors, so stem cells have devolved mitochondrial infrastructure and function to rely on glycolysis and the pentose phosphate pathway. Although these
pathways release a fraction of energy stored in a glucose molecule, producing a net 2 ATP compared to 36–38 ATP for complete oxidation to CO2, they enable
hydrocarbon availability and production of reducing cofactors such as NADPH for biosynthesis. To maintain high rates of glycolysis, in the context of reduced
mitochondrial function, a sufficient NAD+ pool must be regenerated through lactate dehydrogenase. Mitochondria may contribute to anabolism through cata-
plerosis, consisting of incomplete substrate oxidation and extraction of TCA intermediates to produce cytosolic products, such as acetyl-CoA and glutamine, and
by harboring pathways essential for stem cell function, such as theronine metabolism and purine biosynthesis. ADP, adenosine diphosphate; ATP, adenosine
triphosphate; NAD+, nicotinamide adenine dinucleotide; NADH, reduced nicotinamide adenine dinucleotide; NADP, nicotinamide adenine dinucleotide phos-
phate; NADPH, reduced nicotinamide adenine dinucleotide phosphate; P, phosphate.
598 Cell Stem Cell 11, November 2, 2012 ª2012 Elsevier Inc.
Cell Stem Cell
Perspective
R
eprogram
m
ing
lleCSPilleCmetS
sisylocylGsisylocylG Oxidative Metabolism
D
iff
er
en
tia
tio
n
Cardiomyocyte
Neuron
Adipocyte
Fibroblast
Figure 3. Metabolic Plasticity Enables
Departure from and Reacquisition of
Stemness
While a predominantly glycolytic metabotype
provides sufficient energy to support stem cells in
their basal state, maturation of an efficient and
robust metabolic network is required to match
evolving energetic demands of increasingly
specialized progeny. Establishment of the oxida-
tive metabolism infrastructure is realized through
mitochondrial biogenesis and maturation, forming
networks that support flux through the tricarbox-
ylic acid cycle and electron transport chain. Mito-
chondrial oxidization of pyruvate and glutamine
to CO2 is evolutionarily optimized to efficiently
extract maximal energetic currency. A concomi-
tant rise in mitochondrial reactive oxygen species
may prime stem cells for lineage differentiation.
Nuclear reprogramming initiates reversal of the
developmental paradigm, such that glycolysis is
recommissioned at the expense of oxidative
metabolism, associated with regression of oxida-
tive and mitochondrial infrastructure to a primor-
dial (embryonic-like) state.
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Lonergan et al., 2007).
Consistent with immature mitochondrial morphology, oxida-
tive capacity is reduced and glycolysis-dependent anabolic
pathways are enriched in stem cells including ESCs (Cho et al.,
2006; Chung et al., 2007; Folmes et al., 2011a; Kondoh et al.,
2007), long-term HSCs (Simsek et al., 2010), MSCs (Chen
et al., 2008b), and hepatic stem cells (Turner et al., 2008). Stimu-
lation of glycolysis in pluripotent stem cells, through hypoxia
(Ezashi et al., 2005; Mohyeldin et al., 2010), inhibition of mito-
chondrial respiration (Varum et al., 2009), or supplementation
with insulin (Chen et al., 2011), promotes stemness while inhibi-
tion of glycolysis halts proliferation and precipitates cell death
(Kondoh et al., 2007). ESCs also have a high requirement for thre-
onine metabolism to fuel anabolic pathways such as purine
synthesis, with threonine withdrawal impairing cell growth and
depleting stem cell markers (Wang et al., 2009). Core pluripo-
tency circuitry, including the OCT4, SOX2, and NANOG subset,
shares points of convergence with STAT3, a master metabolic
regulator controlling the oxidative to glycolytic switch (Chen
et al., 2008c; Demaria et al., 2010). Specifically, the stemness
factor OCT4 has a number of targets associated with energy
metabolism, which may impact the balance between glycolysis
(pyruvate carboxylase and hexokinase 1) and oxidative metabo-
lism (NDUFA3, ATP5D, and ATP5f1) (Chen et al., 2008c; Kang
et al., 2009; Shakya et al., 2009). Loss of an OCT family member,
OCT1, induces a metabolic shift away from glycolysis in favor of
mitochondrial oxidative metabolism (Shakya et al., 2009). Chro-
matin modifiers, such as polycomb repressor complexes, which
promote pluripotency, also targetmetabolic enzymeswithin their
active gene sets (Brookes et al., 2012; Dang, 2012). Moreover,
kinase inhibitors (2i), which streamline germline-competent
ESCderivation and prevent spontaneous differentiation, upregu-
late genes associated with metabolic functions (Marks et al.,
2012). Key stemness transcriptional programs thus regulate
energy metabolism to promote stem cell homeostasis.
Oxidative Metabolism in Stem Cell Fate Specification
Development, envisioned in Waddington’s landscape, depicts
gravity propelling a ball from a peak, representing pluripotency,to settle in local minimum elevation points of stable cell states
(Enver et al., 2009). From the perspective of cell metabolism,
the hills within the landscape represent thermodynamic
barriers that segregate discrete cell states, with valleys corre-
sponding to the minimum energetic paths connecting states,
indicating that a specific metabolic capacity is required to over-
come barriers to state conversion. Indeed, the energetic require-
ments of stem cells and their progeny differ; differentiated
cells no longer need to sustain high rates of replication and
thus have lower anabolic demands, but they require large
amounts of energy to fuel the processes of cellular homeostasis
and increasingly specialized functions of the progeny, such as
sustained contraction in cardiomyocytes or electrical impulses
in neurons (Folmes et al., 2012a). The lower requirement for
anabolic precursors enables differentiated cells to catabolize
substrates in a more energy efficient manner through complete
oxidation within the TCA cycle, transfer of reducing equivalents
to the electron transport chain, and production of ATP through
oxidative phosphorylation, which for glucose produces 36 to
38 ATP compared to 2 ATP for glycolysis. Prioritization of
discrete metabolic pathways offers a mechanism to align bio-
energetic needs with evolving identities and specialized func-
tions (Figure 3).
Metabolomic comparison of ESCs and their differentiated
progeny identified a global enrichment of unsaturated metabo-
lites in the pluripotent state (Yanes et al., 2010). Metabolites
with a high degree of structural unsaturation contain a number
of carbon-carbon double and triple bonds, which renders
them reactive and readily susceptible to oxidative reactions.
The unsaturated metabolome may prime ESCs to differentiate
in response to oxidative processes, as levels of these metabo-
lites decrease upon differentiation. In support of this concept,
inhibition of the eicosanoid pathway in ESCs, which maintains
high levels of unsaturated fatty acids, preserves pluripotency,
while addition of saturated metabolites to ESC media supports
oxidative metabolism and accelerates lineage specification
(Yanes et al., 2010). Consistent with an energetically privileged
(primed) state, pluripotent cells display hyperpolarized mito-
chondria (Chung et al., 2007; Folmes et al., 2011a), poised toCell Stem Cell 11, November 2, 2012 ª2012 Elsevier Inc. 599
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through efficient oxidative metabolism. Mitochondrial infra-
structure and function can impact differentiation propensity
independent of initial pluripotent features (Folmes et al.,
2012b). ESCs with high resting mitochondrial membrane poten-
tial have more efficient teratoma formation and less efficient
mesodermal differentiation compared to counterparts displaying
low mitochondrial potential (Schieke et al., 2008). Redistribution
of mitochondria from the perinuclear space throughout the
cytosol during extended passaging of MSCs is associated
with greater spontaneous differentiation (Lonergan et al.,
2006). Slow-dividing mesoangioblasts, a precommitted cardiac
progenitor cell, have extensive mitochondria and efficiently
differentiate into cardiomyocytes, while their fast-dividing coun-
terparts have few mitochondria that cannot support cardiac
differentiation (San Martin et al., 2011). Stimulation of mitochon-
dria biogenesis can overcome the differentiation block in fast-
dividing cells, while reducing mitochondrial content perturbs
cardiomyocyte differentiation in slow-dividing cells (San Martin
et al., 2011). Mitochondrial and metabolic infrastructure thus
prime stem cells for differentiation.
When induced to differentiate, ESCs and MSCs downregulate
stemness genes and stimulate mtDNA replication in support
of mitochondrial biogenesis and maturation of extensive and
interconnected networks of elongated and cristae-rich mito-
chondria (Chen et al., 2008b; Cho et al., 2006; Chung et al.,
2007; Facucho-Oliveira et al., 2007; Lonergan et al., 2006). In
parallel, upregulation of TCA cycle enzymes and electron trans-
port chain subunits, and downregulation of glycolysis, increases
mitochondrial capacity, enabling accelerated respiration and
more efficient ATP production (Chung et al., 2007; Tormos
et al., 2011). Transition from glycolysis to mitochondrial oxida-
tive metabolism and maintenance of mitochondrial electron
transport function is critical for differentiation. As glycolysis
and oxidative metabolism are reciprocally regulated, inhibition
of the mitochondrial electron transport chain impairs ESC
differentiation (Chung et al., 2007; Mandal et al., 2011), while
inhibition of key enzymes in glycolysis (phosphoglycerate
kinase) and the pentose phosphate pathway (hexose-phos-
phate dehydrogenase) promotes myogenic differentiation
(Bracha et al., 2010). In addition, suppression of the uncoupling
protein 2 (UCP2)-dependent glucose supply during differentia-
tion reduces glycolytic capacity and contributes to the transition
into oxidative metabolism and lineage specification (Zhang
et al., 2011). Mitochondrial maturation and electron transport
function also significantly impact in vivo differentiation. Early
cardiomyocytes display immature mitochondrial morphology
associated with an open mitochondrial permeability transition
pore (mPTP), which dissipates ion and metabolite gradients,
reduces mitochondrial membrane potential, and uncouples
oxidative metabolism from ATP synthesis (Hom et al., 2011).
mPTP closure promotes mitochondrial structural and functional
maturation supporting cardiomyocyte differentiation, while sus-
tained mPTP opening retains immature mitochondria and
impairs differentiation (Folmes et al., 2012b; Hom et al., 2011).
Thus, maturation of mitochondrial function and energetically
efficient oxidative metabolism match the emerging energetic
demands of differentiation and specialized function of differen-
tiated progeny.600 Cell Stem Cell 11, November 2, 2012 ª2012 Elsevier Inc.Mitochondrial function and oxidative metabolism correlate
with stem cell differentiation; however, the mechanistic under-
pinnings of a causal role in cell fate determination remain to be
elucidated. To date, emphasis has been placed onmitochondrial
regulation of reactive oxygen species (ROS) as inductors of stem
cell differentiation (Hom et al., 2011; Owusu-Ansah and Bane-
rjee, 2009; Tormos et al., 2011; Zhang et al., 2011). Indeed, anti-
oxidant treatment impairs the ability of MSCs and HSCs to
undergo differentiation (Owusu-Ansah and Banerjee, 2009;
Tormos et al., 2011); however, the targets of ROS in differen-
tiation programs remain unknown. Metabolic pathways are
also increasingly recognized to interact with epigenetic regu-
lation of gene expression, impacting differentiation programs
and promoting prolineage signaling (Wellen and Thompson,
2012).
Metabolic Requirements for Stem Cell Quiescence
Adult stem cell populations, such as HSCs, hair follicle stem
cells, or muscle satellite cells, maintain a slow cycling (quiescent)
state as a mechanism to avoid accumulation of cellular damage
from stress and to ensure life-long tissue renewal (Suda et al.,
2011). Quiescent HSCswith long-term (LT) reconstitution activity
demonstrate lower mitochondrial membrane potential, oxygen
consumption, and ATP levels, and have greater reliance on
glycolytic flux than whole bone marrow (Simsek et al., 2010).
The small numbers of mitochondria are tightly controlled
because mitochondrial biogenesis can result in defective main-
tenance of the HSC pool (Chen et al., 2008a). In fact, the majority
of LT-HSCs can be metabolically sorted by gating for low
mitochondrial membrane potential and low endogenous NADH
fluorescence, and were shown to have greater capacity for
in vitro colony formation and in vivo bone marrow reconstitution
(Simsek et al., 2010). Unlike rapidly proliferating stem cells that
rely on glycolysis to fulfill the anabolic requirements for replica-
tion, LT-HSCs may utilize energetically inefficient glycolytic
ATP generation due to the lower energy demand of the quiescent
state and in order to prevent cellular damage frommitochondria-
derived ROS. This metabolic phenotype may also be largely
dependent upon the hypoxic niche within the bone marrow in
which these cells normally reside (Suda et al., 2011). Hypoxia
stabilizes hypoxia inducible factors (HIFs) by suppressing degra-
dation of their alpha subunits, which enables HIF-heterodimer
formation and binding to hypoxia response elements in target
genes (Suda et al., 2011). HIF1 activity promotes an oxidative
metabolism to glycolysis switch through transcriptional activa-
tion of genes that regulate glucose uptake (Glut1) and pyruvate
disposal (Ldha and Pdk1) (Suda et al., 2011; Zhou et al., 2012).
To this end, the glycolytic phenotype appears to be dependent
upon transcriptional activation of HIF1a through the HSC tran-
scription factor MEIS1 (Simsek et al., 2010). This is consistent
with the observation that genetic deletion of HIF1 subunits
results in defective hematopoiesis, vascularization, and neural-
fold closure, resulting in embryonic lethality (Mohyeldin et al.,
2010; Takubo et al., 2010). HIFs also interact with core stemness
networks, because HIF2a can upregulate OCT4 expression
and modulate Wnt/b-catenin signaling, while silencing of
HIF2a and HIF3a decreases expression of NANOG, SOX2, and
OCT4 (Covello et al., 2006; Forristal et al., 2010; Mazumdar
et al., 2010). Muscle satellite cells also demonstrate extensive
metabolic flexibility, whereby they reduce mitochondrial mass
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entrance into a dormant state and postmortem survival (Latil
et al., 2012).
The PI3K-mTOR pathway, a key metabolic signaling axis,
regulates the balance between HSC quiescence and prolife-
ration (Chen et al., 2008a; Kalaitzidis et al., 2012; Kentsis and
Look, 2012; Magee et al., 2012; Valcourt et al., 2012). However,
the effect of this pathway on HSC metabolism remains largely
unaddressed, with the exception that deletion of tuberous
sclerosis complex 1, an upstream negative regulator of mTOR,
increases mitochondrial biogenesis, driving HSCs from a quies-
cent to a rapidly cycling state and ultimately depleting the stem
cell pool and impairing hematopoiesis (Chen et al., 2008a).
Deletion of another metabolic sensor and signaling molecule,
LKB1, in HSCs precipitates death due to loss of quiescence,
depletion of HSC and progenitor pools, and impaired reconstitu-
tion capacity (Gan et al., 2010; Gurumurthy et al., 2010; Nakada
et al., 2010). Loss of LKB1 reduces mtDNA copy number, mito-
chondrial membrane potential, and oxidative capacity, and is
associated with reduced ATP levels. LKB1-deficient HSCs
have prominent elevation of long-chain fatty acids and nucleo-
tide metabolites, as well as modifications in glycolytic and TCA
components, indicating an essential role of LKB1 in HSC meta-
bolic homeostasis (Gurumurthy et al., 2010). LKB1 deficiency
reduces phosphorylation of its downstream target AMPK
(T172) and knockout of AMPK a1/a2 partially recapitulates the
phenotype. However, activation of signaling pathways down-
stream of AMPK, includingmTOR and FOXO, is unable to rescue
HSC function, indicating that an alternative LKB1 signaling
pathway must also be involved (Gan et al., 2010; Gurumurthy
et al., 2010; Nakada et al., 2010). This alternative pathway may
operate through PGC1a/b, which regulates mitochondria
biogenesis and energy metabolism, since loss of LKB1 reduces
PGC1a/b expression (Gan et al., 2010). Metabolic signaling
and regulation of mitochondrial biogenesis and glycolytic
metabolism play an essential role in maintaining HSCs in the
quiescent state to sustain long-term self-renewal.
Metabolic Reprogramming Fuels Induced Pluripotency
Through nuclear reprogramming, overexpression of stemness
factors resets somatic cells into induced pluripotent stem cells
(iPSCs). This reprogramming recapitulates features of embry-
onic archetypes (Takahashi and Yamanaka, 2006), including
prioritized anabolic processes for generation of cell constituents
(Folmes et al., 2011a). A switch from somatic oxidative
phosphorylation in favor of glycolysis characterizes nuclear
reprogramming (Folmes et al., 2011a; Panopoulos et al., 2012).
Mechanisms for this metabolic decommissioning remain
unknown, yet upregulation of glycolytic genes precedes expres-
sion of pluripotency markers, indicating that recommissioning
glycolysis is an early event in reprogramming to pluripotency
(Folmes et al., 2011a).
Nuclear-reprogramming-associated remodeling of the meta-
bolic infrastructure involves transcriptional and epigenetic re-
configuration of glucose metabolism (Figure 3). This includes
upregulation of genes involved in the initial and final steps of
glycolysis and the nonoxidative branch of the pentose phos-
phate pathway, and downregulation of intermediate reactions
in glycolysis (Prigione et al., 2011; Varum et al., 2011). In addi-
tion, reduction of the mtDNA copy number in the setting ofconstant nuclear encoded mitochondrial gene expression and
upregulation in mitochondrial biogenesis genes underlies
reprogramming (Prigione et al., 2010). Genuine iPSCs demon-
strate targeted upregulation of glycolytic enzymes and selec-
tive downregulation of electron transport chain subunits,
associated with regression in mitochondrial density, distribu-
tion, and ultrastructure (Folmes et al., 2011a; Prigione et al.,
2010; Varum et al., 2011). The metabolic switch manifests
functionally as an increased glycolytic rate associated with
decreased cellular respiration (Folmes et al., 2011a; Varum
et al., 2011).
Somatic sources with a greater glycolytic and lower oxidative
capacity display higher reprogramming efficiency, consistent
with a reduced thermodynamic barrier between parental cells
and resultant iPSCs (Panopoulos et al., 2012). Promotion of
glycolytic metabolism by drugs (Zhu et al., 2010), by hypoxia
(Yoshida et al., 2009), through inhibition of the p53 pathway
(Bensaad et al., 2006; Krizhanovsky and Lowe, 2009), or via
supplementation with glycolytic intermediates augments re-
programming efficiency, while inhibition of glycolysis and/or
stimulation of oxidative metabolism impairs reprogramming
(Folmes et al., 2011a; Zhu et al., 2010). Conversion from oxida-
tive phosphorylation to glycolysis thus underlies reacquisition
of stemness, implicating malleable cell metabolism as a factor
controlling cell fate decisions.Stem Cell Metabolism and (Epi)Genetic Crosstalk
in Control of Cell Fate
Beyond nutrient-sensing pathways that match gene tran-
scription and intercellular/extracellular energetic status,
nutrient-responsive metabolites, such as ATP, acetyl-CoA,
UDP-N-acetylglucosamine (UDP-GlcNAc), and S-adenosyl
methionine, mediate crosstalk between metabolism, cellular
signaling, and epigenetic control of transcription programs
(Wellen and Thompson, 2012). By operating as indicators of
metabolic status, thesemetabolites serve as substrates for post-
translation modifications, including acetylation, glycosylation,
methylation, and phosphorylation, which regulate the activity
of metabolic enzymes, signaling pathways, and transcription
factors (Figure 4). A case in point is the hexosamine biosynthetic
pathway, a branch of glucose metabolism sensitive to glucose,
amino acid, fatty acid, and nucleotide metabolism, which
produces UDP-GlcNAc, a substrate for addition of O-linked-N-
acetylglucosamine (O-GlcNAc) to proteins (Hanover et al.,
2012). This nutrient-sensitive posttranslational modification
regulates the transcriptional activity of core pluripotency
network members, including OCT4 and SOX2 (Jang et al.,
2012). Reducing this posttranslational modification through
inhibition of O-GlcNAc transferase or reducing glucose con-
centrations impairs ESC self-renewal and nuclear reprogram-
ming. Conversely, increasing global O-GlcNAc levels inhibits
differentiation, thus linking metabolic status with fundamental
stem cell function (Jang et al., 2012). UDP-GlcNAc is also
required for N-glycosylation, which regulates the ability of
HSCs to respond to interleukin-3 by controlling the translocation
of its receptor subunit-a to the cell surface (Wellen et al., 2010).
Glucose deprivation impairs receptor translocation and induces
cellular atrophy, while supplementation with GlcNAc restoresCell Stem Cell 11, November 2, 2012 ª2012 Elsevier Inc. 601
Figure 4. Integration of Energy Metabolism with Cell Signaling and Epigenetic Transcriptional Regulation
Partitioning of processes into discrete compartments enables fine regulatory control but presents significant barriers for crosstalk. Accordingly, cells have
evolved transcellular energetic networks of near equilibrium reactions to facilitate transfer from sites of energy production to distant sites of utilization. Devel-
opmental enhancement of such phosphotransfer circuits, including those mediated by adenylate kinase (AK)/creatine kinase (CK), are integral for stem cell
lineage specification. Beyond metabolic rheostats that can sense metabolic status, intermediary metabolism directly interacts with cellular signaling pathways
and transcriptional regulators through posttranslational modification of proteins with nutrient sensitive metabolites. The hexosamine biosynthetic pathway is
a branch point in glucose metabolism that produces UDP-N-acetylglucosamine (UDP-GlcNAc) and is sensitive to glucose, amino acid, fatty acid, and nucleotide
metabolism. In addition, the cytosolic concentration of acetyl-CoA is dependent upon cleavage of TCA cycle-derived citrate (catalyzed by ATP-citrate lyase) or
ligation of acetate and CoA (catalyzed by acetyl-CoA synthetase). UDP-GlcNAc-dependent glycosylation and acetyl-CoA-dependent acetylation of proteins
enables nucleocytoplasmic crosstalk to regulate transcription and translation, nutrient sensing, cell cycle, and energy metabolism that contribute to cell fate
decisions. ADP, adenosine diphosphate; ATP, adenosine triphosphate; Cr, creatine; NAD+, nicotinamide adenine dinucleotide; NADH, reduced nicotinamide
adenine dinucleotide; PCr, phosphocreatine; PPi, pyrophosphate; UTP, uridine triphosphate.
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growth and proliferation (Wellen et al., 2010).
Acetyl-CoA, which is dependent on cleavage of TCA cycle-
derived citrate (catalyzed by ATP-citrate lyase) or ligation of
acetate and CoA (catalyzed by acetyl-CoA synthetase), is a
precursor for acetylation of proteins involved in regulating energy
metabolism, nuclear import, and gene expression (Choudhary
et al., 2009). Inhibition of ATP citrate lyase reduces nuclear
acetyl-CoA and histone acetylation to induce myogenic differ-
entiation (Bracha et al., 2010), while promotion of acetylation
by inhibition of histone deacetylases increases reprogramming
efficiency (Huangfu et al., 2008). In addition, high glycolytic rates
are associated with a rise in acetyl-CoA levels and histone acet-
ylation in yeast and cancer cells (Cai et al., 2011; Friis et al., 2009;
Wellen et al., 2009). Through regulation of acetyl-CoA levels,
early changes in glycolysis may contribute to epigenetic control
of cell fate.
Metabolites are heterogeneously distributed in the cell, parti-
tioned in subcellular compartments that enable efficient control
of cell behavior. Cells have evolved energetic networks to facili-
tate transfer from sites of energy production to sites of utilization,
ensuring information exchange across compartments for regu-
lation of cell growth, proliferation, and differentiation. For
example, maturation of phosphotransfer machinery catalyzed
by creatine kinase/adenylate kinase and associated glycolytic602 Cell Stem Cell 11, November 2, 2012 ª2012 Elsevier Inc.and AMPK signaling is critical for ESC cardiac lineage specifica-
tion (Chung et al., 2008; 2010; Dzeja et al., 2011). Interaction of
energy metabolism with transcriptional regulators and cellular
signaling thus has a significant impact on defining stem cell fate.
Metabolism Fuels Adult Regeneration
Postnatally and throughout aging, there is a decline in the
ability of tissues to self-renew. The neonatal mammalian heart
demonstrates a significant capacity to repair, yet vigorous innate
regeneration is lost by 1 week of birth and continues to wane
with age (Bergmann et al., 2009; Porrello et al., 2011). Aging-
associated decline is consistent across tissues, resulting in
slower wound healing, reduced muscle mass and neurogenesis,
hair loss, and changes in blood cell type distribution (Liu and
Rando, 2011). Tissue homeostasis and regeneration depends
on resident progenitor cell function and availability, and is con-
sistent with the observation that genetic depletion of tissue-
specific progenitors results in premature aging (Sahin and
Depinho, 2010). Accumulation of genomic and mtDNA muta-
tions place cellular functions at risk and are correlated with
aging. Elevated mtDNA mutation rates decrease lifespan,
impair stem cell self-renewal, and induce abnormal lineage
differentiation during embryogenesis, which manifests as
progeria and respiratory chain deficiency (Ahlqvist et al.,
2012). Aging-associated signaling pathways can also induce
Cell Stem Cell
Perspectivemitochondrial dysfunction and increase generation of ROS that
compromise stem cell proficiency, which can be blunted with
the use of antioxidants (Sahin and Depinho, 2010). The systemic
environment also significantly impacts the function of resident
stem cells, with muscle and liver cells rejuvenated to a more
youthful state when exposed to a young environment, and
young cells adopting an aged phenotype in response to an
aged environment (Conboy et al., 2005; Liu and Rando, 2011).
Nutrient-sensitive signaling pathways that regulate lifespan and
energy metabolism, such as those mediated by AMPK, FOXO,
insulin/IGF1, and mTOR, impact stem cell function (Jasper and
Jones, 2010; Renault et al., 2009). Stemness is maintained in
response to signals of plenty (insulin signaling and abundant
amino acids), while signal reduction during starvation induces
differentiation (Shim et al., 2012). Inhibition of mTOR with rapa-
mycin extends lifespan of mice and restores self-renewal and
hematopoiesis of aged HSCs (Chen et al., 2009; Harrison
et al., 2009). Signaling pathways that regulate aging and stem
cell function may collectively converge on energy metabolism,
which functions as a rheostat to regulate self-renewal and differ-
entiation.
Caloric restriction promotes self-renewal but not differentia-
tion of intestinal stem cells, resulting in an increased number of
Paneth cells and intestinal stem cells at the base of intestinal
crypts (Yilmaz et al., 2012). This effect is mediated through Pan-
eth-cell-specific inhibition of the energy sensor mTORC1 and
upregulation of bone marrow stromal antigen I and its product
ADP ribose, which induces intestinal stem cell proliferation and
increases regenerative capacity (Yilmaz et al., 2012). Caloric
restriction boosts the number and myogenic function of skeletal
muscle stem cells, which is associated with the expression of
the metabolic regulators SIRT1 and FOXO3A, mitochondrial
biogenesis, and enhanced oxidative metabolism at the expense
of glycolysis (Cerletti et al., 2012). The promyogenic effect of
caloric restriction is recapitulated in vitro by replacing glucose
with galactose to force the use of oxidative metabolism, and
blocked by inhibiting fatty acid oxidation (Cerletti et al., 2012).
A selective metabolic pressure during cell repopulation upon
injury in skeletal muscle favors preferential expansion of pro-
genitors harboring wild-type over mutant mtDNA genotype, to
support a healthy metabolic phenotype (Clark et al., 1997).
Selection of stress-resistant progenitors following rejuvenation
is further suggested with the clinical observation that continuous
hematopoiesis in mitochondrial disease leads to mtDNA transi-
tion toward a wild-type phenotype (Rajasimha et al., 2008).
These examples highlight natural mechanisms that are sufficient
to reset dysfunctional metabolism in progenitor cells that are
necessary to give rise to regenerating, functional tissues.
Applying regenerative metabolism principles to rejuvenate
stem cell metabolism has the potential to deterministically alter
the fate of differentiating tissues for improved function and repair
capacity in aging and/or disease. As a paradigm of metabolic
repair, MSCs demonstrate a capacity to transfer mitochondria
and rescue aerobic respiration in cells lacking mitochondria
(Spees et al., 2006). Mitochondrial transfer has also been
observed during stem cell therapy following lung injury, resulting
in elevated alveolar ATP levels, which contributes to protection
and repair of pulmonary alveoli (Islam et al., 2012). Next-genera-
tion regenerative platforms with optimized stem cell metabolismwill thus be equipped to titrate metabolic competencies and
accordingly regenerate tissues and organs.
Concluding Remarks
The way stem cells use energy and intermediate metabolites
determines their prospects. Metabolic regimes shape self-
renewal proficiency, and fuel interconversion of versatile lineage
identities. The orchestrated commissioning and decommission-
ing of metabolic pathways enables stem cell differentiation, and
also supports reacquisition of pluripotency. Complementing
genetic determinants of programming and reprogramming, the
plasticity in energy metabolism is now recognized as a prerequi-
site in fulfilling the energetic needs of cell fate decisions. In this
emerging area, initial evidence links energy metabolism with
cell signaling and epigenetic regulation of gene expression.
Advances in resolving the metabolome as a whole, and its
dynamics, offer an unprecedented opportunity to map the
evolving bioenergetics of organogenesis and establish a blue-
print for targeted control of cell fate. Translation of insights
gained from developmental metabolomics paves the way for
a novel paradigm in tailored rejuvenation/regeneration strategies
aimed at restoring compromised stem cell metabolism in aging
and disease.
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